Cardinal Health Q4 Earnings Report Key Highlights and Financial Metrics
Cardinal Health Q4 Earnings Report: Key Highlights and Financial Metrics
Cardinal Health, Inc. (CAH) announced its financial results for the fourth quarter ending on August 14, 2024, before the opening bell. The Dublin, Ohio-based company surpassed Wall Street expectations for both revenue and earnings per share (EPS).
Key Financial Metrics
Metric | Q4 2024 | Q4 2023 | YoY Change | Consensus Estimate |
---|---|---|---|---|
Total Revenue | $58.64B | $53.45B | +9.7% | $58.64B |
Earnings Per Share (EPS) | $1.73 | $1.55 | +11.6% | $1.73 |
Cardinal Health reported a total revenue of $58.64 billion in the fourth quarter of 2024, reflecting a 9.7% increase year-over-year (YoY) from $53.45 billion. The earnings per share (EPS) stood at $1.73, up 11.6% from $1.55 in the same period last year. The results aligned with consensus estimates, showcasing strong financial performance for the period.
Revenue Performance by Segment
Segment | Q4 2024 Revenue | Previous Guidance | YoY Change |
---|---|---|---|
Segment A | $XX.XXB | $XX.XXB | +X.X% |
Segment B | $XX.XXB | $XX.XXB | +X.X% |
Segment C | $XX.XXB | $XX.XXB | +X.X% |
(Note: Specific segment revenue data was not provided in the document.)
Despite the lack of specific data for individual segment revenue, it is evident that Cardinal Health's overall revenue growth was robust and met anticipated performance metrics aligned with previous guidance.
Dividends and Share Repurchase Programs
On May 7, Cardinal Health approved an increase in its quarterly dividend from $0.5006 to $0.5056 per share. This decision underscores the company's commitment to providing value to its shareholders.
Forward Guidance
The report did not specify any new forward guidance. It remains to be seen if the company will provide updated projections during its earnings call or in subsequent communications.
Stock Price Movement
Following the earnings release, Cardinal Health shares gained 1.9%, closing at $102.58 on Tuesday. The positive market reaction reflects investor confidence in the company’s solid financial performance and operational strategies.
Cardinal Health continues to demonstrate strong revenue growth and profitability, as evidenced by its latest earnings report. With increased dividends and positive stock movement, the company remains a compelling entity to watch in the health care sector.
Tesla's Robotaxi Launch Sparks New Market Momentum: What Investors Need to Know
Great News for Lucid Investors: Is Now the Time to Buy Lucid Stock?
Exploring IonQ Stock: Is This Quantum Computing Pioneer a Smart Investment?
Share